Patient‐Reported Outcomes in Oncology Clinical Trials: Stakeholder Perspectives from the Accelerating Anticancer Agent Development and Validation Workshop 2019

The measurement and analysis of patient‐reported outcomes is important in cancer clinical trials. This commentary reports advances and challenges from presentations at the 2019 Accelerating Anticancer Agent Development and Validation (AAADV) Workshop Patient‐Reported Outcomes Session.

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Bhatnagar, Vishal, Hudgens, Stacie, Piault‐Louis, Elisabeth, Jones, Lee, Beaver, Julia A., Lyerly, H. Kim, Reaman, Gregory, Fleming, Thomas, Kluetz, Paul G.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2020
Assuntos:
Commentaries
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7543246/
https://ncbi.nlm.nih.gov/pubmed/32463153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2020-0062
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados